One action to enhance your daily routine and boost balance, self-fulfilment, and confidence, whether at work or home— what would it be? Improving our wellness doesn't need a complete overhaul. It's not about dramatic transformations or being 'all in' from day one. Often, just one small step is enough. At Roche, the health and wellbeing of our employees are our priority, ingrained in our DNA. We constantly evolve wellbeing programmes, and every September, the Live Well Weeks encourage everyone to find ways to improve their wellbeing. Be part of #OneChangeChallenge and share your thoughts in the comments below 👇 #LiveWellWeeks2024
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
In recognition of 20 years of #WLAD, what are your hopes for the next 20 years in #lymphoma research? Hear from Michelle Boyer, Global Head of Product Development, Lymphoma, at Roche, who shares her hopes for the future of lymphoma care and discusses the importance of #HonestTalk between patients and healthcare teams to help define treatment goals and improve outcomes. 👇
-
Watch our Cancer Dialogue video to hear Charles Fuchs’ and Luis Paz-Ares' thoughts on the most pressing challenges to overcome in cancer care: http://spkl.io/6049f1aUd Despite significant advances in oncology over the last few years, there are still many areas where we need to deepen our scientific understanding, drive innovation and improve outcomes for patients. In our first episode of Cancer Dialogue, Charles Fuchs and Luis Paz-Ares come together at #ESMO24 to share their thoughts on advancing research, further improving cancer care and making a meaningful difference to patients’ lives.
-
At Roche, we harness cutting-edge technology and scientific expertise to deliver targeted innovations and enhance early detection. Together with partners like Union for International Cancer Control (UICC) we are developing scalable, sustainable solutions to improve outcomes for cancer patients worldwide. Curious to know more? Read the reflections Michael Oberreiter and Dr Cary Adams on the future of cancer care and innovation. #WCC2024 #InnovationInCancerCare #Roche #Partnerships #HealthInnovation
-
The United Nations General Assembly (UNGA) is taking place this month as global leaders meet to shape solutions for our future. As leaders discuss important global health topics like antimicrobial resistance and health security, they will need to consider new approaches to investing in healthcare in general 💡 Tamara Schudel VP & Head of Global Policy at Roche, will be at #UNGA speaking to global health and policy leaders about the need to reconsider health as a strategic investment, rather than a cost. You can learn more about the investment case for health, why we must tackle antimicrobial resistance through a multi-sectoral approach and more here. 👉 http://spkl.io/6043fEvD5 #UNGA #Roche #HealthcareInnovation
-
In our first edition of ‘Cancer Dialogue’, Charles Fuchs, Global Head of Oncology & Hematology Drug Development at Roche and Genentech, sits down with Luis Paz-Ares, Head of Medical Oncology Department Hospital Universitario 12 de Octubre, at #ESMO24 to explore the biggest and most urgent challenges in oncology. Watch Luis answer and the full conversation here: http://spkl.io/6042fDQGG
-
Are you ready to be part of something bigger than yourself❓ Join our amazing community where your passions and talents can make a real difference. Whether it's through groundbreaking projects, meaningful connections, or unforgettable experiences, there's a place for you here. 🔍 Discover new opportunities. 🤝 Connect with like-minded individuals. 🌍 Make an impact. Don’t just watch — become a part of something greater. Your journey starts now. 🚀 Find more information about Community & Culture at Roche: https://lnkd.in/dmHgZRWQ
-
What sparks your interest when you think of oncology innovation and the future of cancer care? Learn from leading oncology experts as we explore some of the key developments in the space and what they may mean for cancer care in our new video series ‘Cancer Dialogue’. Stay tuned over #ESMO24 as we share the first edition of the series. What would you like to see discussed in the ‘Cancer Dialogue’ series? Comment below and have your say!
-
Reflecting on #ERSCongress, we are both inspired by the progress in the field and reminded of the significant burden respiratory conditions like chronic obstructive pulmonary disease (COPD) pose. Bringing together the minds behind the research and initiatives, the #ERSCongress is powering change in respiratory health. Through collaboration with leaders across the respiratory community, we can expand our understanding of complex diseases, such as #COPD and bring positive change for the millions affected. To learn more, click here: http://spkl.io/6048f8XxQ
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Letzte Runde
Kapitalerhöhung nach Börsengang5.000.000.000,00 $
Investor:innen
SoftBank